ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Zafgen Inc

Zafgen Inc (ZFGN)

0.99
0.00
(0.00%)
Cerrado 11 Diciembre 3:00PM
0.99
0.00
( 0.00% )
Pre Mercado: 6:00PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
0.99
Postura de Compra
0.9801
Postura de Venta
0.99
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
0.99
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
43,906,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.18
Beneficio por acción (BPA)
-0.84
turnover
-
Beneficio neto
-36.95M

Acerca de Zafgen Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-

ZFGN Últimas noticias

Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results

Zafgen and Chondrial Therapeutics previously announced a definitive merger agreement Merger creates clinical-stage company focused on the development of novel protein replacement therapies for...

Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement

Creates clinical-stage company focused on the development of novel protein replacement therapies for rare diseases Chondrial Therapeutics’ lead asset, CTI-1601, currently being evaluated in Phase...

Zafgen Reports Third Quarter 2019 Financial Results

Evaluation of strategic alternatives ongoing BOSTON, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN) today reported its third quarter 2019 financial results. In September 2019...

Zafgen to Explore Strategic Alternatives

BOSTON, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Reports Second Quarter 2019 Operating and Financial Results

Agreement reached with U.S. FDA on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study...

Zafgen to Present at the Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Announces Agreement with U.S. Food and Drug Administration on New Nonclinical Study Design for ZGN-1061

Alignment reached on in vivo animal study design and protocol to translate work from novel in vitro assays and establish relevant safety margins Topline data from the in vivo study expected by...

Zafgen to Present at the JMP Securities Life Sciences Conference

BOSTON, June 13, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...

Zafgen Presented Full Results of Phase 2 Clinical Trial for ZGN-1061 at the American Diabetes Association's 79th Scientific S...

Delivered comprehensive oral presentation on both cohorts of the clinical trial, including previously announced results for second cohort evaluating doses up to 1.8 mg Company also presented data...

Zafgen Announces Regulatory Update on ZGN-1061

Received FDA Type A meeting minutes related to previously announced clinical hold FDA acknowledged newly developed in vitro assays of human plasma coagulation and tissue factor expression...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
TRVITrevi Therapeutics Inc
US$ 3.40
(36.55%)
2.47M
ZENAZenaTech Inc
US$ 7.46
(31.11%)
3.6M
ATLNAtlantic International Corporation
US$ 7.00
(22.74%)
1
KROSKeros Therapeutics Inc
US$ 18.78
(-72.64%)
609.66k
SPGCSacks Parente Golf Inc
US$ 0.50
(-64.29%)
163.73k
PNBKPatriot National Bancorp Inc
US$ 1.08
(-58.78%)
16
AVGRAvinger Inc
US$ 0.441
(-46.22%)
87.3k
HEPAHepion Pharmaceuticals Inc
US$ 0.36
(-38.46%)
1
PALIPalisade Bio Inc
US$ 3.20
(128.57%)
20.1M
CDTConduit Pharmaceuticals Inc
US$ 0.1012
(14.61%)
14.2M
AMPGAmplitech Group Inc
US$ 2.20
(13.99%)
13.48M
SYTASiyata Mobile Inc
US$ 1.05
(40.37%)
12.24M
LAESSEALSQ Corporation
US$ 1.245
(8.26%)
8.74M
Lonewolf1 Lonewolf1 2 minutos hace
LOL - Trend Trade on this board is the greatest assurance we have that this ticker will FLY!

He is here to save us from holding to $.10+

(Or maybe much higher)

Tick tock.....
CGAC
TMaga TMaga 3 minutos hace
$1.20 4 days left for your windfall
HCWC
gumzsa gumzsa 3 minutos hace
Honestly at this point we get it. You think Josh is a blowhard and that's fine but judging by all your long winded posts saying the same thing over and over you might wanna look in the mirror and chill out too.
AZRH
tw0122 tw0122 3 minutos hace
Up to $4s coming down now $3.80s..
Company plans registration statement amendment to reduce share subscription facility shares from 40,000,000 shares to $15,000,000 (~4.4M
SRFM
arachnodude arachnodude 3 minutos hace
The KBLB Rising Sun

A new day dawns, the horizon glows,
Where hope and light through darkness flows.
The trolls may linger, their words may sting,
But progress is a brighter thing.

Each thread of silk, a beam of gold,
A story of triumph yet u
KBLB
Invest-in-America Invest-in-America 4 minutos hace
BURU: All my joking aside, I'm in. (Something going on here, besides their simple "COMPLIANCE" routine, IMO.)
BURU
SniffinPennies SniffinPennies 4 minutos hace
If your a day trader maybe so, but many that buy stocks for trade don't want the skitzo life of a day trader, they buy on future events and yes it's a huge gamble. but then so is the lotto
CGAC
camelion camelion 4 minutos hace
Total let down imo
HIRU
trusttheman trusttheman 5 minutos hace
Will the morons running this company ever run this thing out or will they just continue to get lawsuits against them?
TPTW
Zadie420 Zadie420 5 minutos hace
You busted that POS and leir. Great job DD as always. Unbelievable what theses go and spread lies and FUD. These people are criminals and need to be jailed because they are dealing with cancer patients lives.
NWBO
badog badog 5 minutos hace
Krom...what dribble!

Badog
ERHE
resx18 resx18 5 minutos hace
Edward Vakser, AURI’s CEO is quoted as saying, “This is an opportunity that we have
been working on for several years. It is the perfect market, and the perfect time to
launch in Europe, who’s regulations are currently much more open than those in the
USA. Moldova alone has sign
AURI
meitze meitze 5 minutos hace
Some believe in XERI and some don't. Smarty has always been consistent in his belief in Duffy and Xeriant. Never have i heard him waiver even with the delays, the stringing along, the strange video conferences, and the failures. Some of the Bearish comments are justified and some of the comments fro
XERI
Nihil8 Nihil8 5 minutos hace
Hi_Lo is right.  Anyone saying otherwise is Kramer or Black on a burner account slow rolling the death of this ticker to reduce the potential for blowback.

They do not have any skin in the game at all because they already made their money pumping as we went into EM.

We
CNNA
TMaga TMaga 5 minutos hace
As reported by Humble himself "-Approximately $3M of HCMC cash reserves"
That is why no $5 million buyback in HCMC Just lied about everything
HCMC
BigBadWolf BigBadWolf 5 minutos hace
$AXXA 0.0007 52 Week Range 0.00315

Your $ base it’s use on your DD & GL w/ any decisions (whether buy, sell or….)
AXXA
trusttheman trusttheman 6 minutos hace
You can see here the way this stock is shorted and has been for a very long time.

https://www.otcshortreport.com/company/UEEC
UEEC
harry crumb harry crumb 6 minutos hace
Lol, we wouldn't buy this with monopoly money! They'l be under attack til this is delisted from fraud, matter of time. Junk
ILLR
TrendTrade2016 TrendTrade2016 6 minutos hace
CHASERS HERE GOT DECIMATED
BCDS
SHEEPWOLF SHEEPWOLF 6 minutos hace
$ILLR: MOST UNDEVALUED SOCIAL MEDIA COMPANY. #OPPORTUNITY
We're talking about a social media disruptor.
FIGHT HARD NOT TO BE DISMISSIVE!
https://investorshub.advfn.com/uimage/uploads/2024/12/9/jvmjkimageedit_4_3337210397.jpg
ILLR
deri21 deri21 6 minutos hace
$AURI AURI Inc. is excited to announce that it will launch it’s Crypto Coins all throughout Europe!
https://www.otcmarkets.com/otcapi/company/dns/news/document/79103/content
AURI
resx18 resx18 6 minutos hace
DALLAS, TX- December 12th, 2024 - AURI Inc. (OTCPK: AURI) (the Company)
AURI Inc., announces a definitive collaboration with the country of Moldova, an EU
friendly nation, to launch the company’s crypto coins and tokens all throughout Europe.
Edward Vakser, AURI’s CEO is quoted
AURI

Su Consulta Reciente

Delayed Upgrade Clock